Alert detail
FDA Approval: VELPHORO (SUCROFERRIC OXYHYDROXIDE) — Type 5 - New Formulation or New Manufacturer
Policy ID: FDA-NDA205109Specialty: ESRDAdded: 10/17/2026Effective: 2013-11-27federal register
What changed
New FDA drug approval. Coverage and billing pathway depend on the FDA label and applicable Medicare LCDs/NCDs — for very recent approvals the label may not be posted yet. Verify against the FDA label and current coverage policy before billing.
Who’s affected: ESRD billing teams · Effective: 2013-11-27
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.